HR2934-119

Introduced

To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marijuana, and for other purposes.

119th Congress Introduced Apr 17, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

Known as the STATES 2.0 Act, this bill would prevent federal marijuana laws from applying to activities that comply with state law. It empowers states and federally recognized Indian tribes to set their own marijuana policies without federal interference. Interstate marijuana transport would be allowed between states that both permit it. The bill directs the FDA to regulate marijuana products the same way it regulates alcohol-containing food, and requires the FDA to issue regulations for marijuana products not covered by existing drug, food, or cosmetic categories within 180 days. Marijuana in compliance with state law would be removed from the federal controlled substances schedule. The bill also prohibits marketing marijuana products in combination with drugs, tobacco, or alcohol, and mandates a GAO study on the effects of marijuana legalization on traffic safety.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Exempt state-legal marijuana activities from the Controlled Substances Act, enable interstate marijuana commerce between legal states, establish FDA regulatory framework for marijuana products, create a federal excise tax, support tribal sovereignty over marijuana regulation, and mandate a traffic safety study.

Who Benefits

  • State-legal cannabis businesses
  • States with legal marijuana
  • Indian tribes

Who Bears Costs

  • Illicit marijuana market operators
  • Federal drug enforcement agencies (reduced jurisdiction)
  • Anti-marijuana advocacy groups

Key Policy Areas

{'domain': 'Drug Policy', 'evidence': 'Amends Controlled Substances Act to exempt state-legal marijuana from federal prohibition'}, {'domain': 'FDA Regulation', 'evidence': 'Section 7 establishes FDA authority over marijuana products as drugs, food, cosmetics'}, {'domain': 'Interstate Commerce', 'evidence': 'Section 4(c) enables interstate marijuana transportation between legal states'}, {'domain': 'Tribal Sovereignty', 'evidence': 'Sections 3-4 recognize tribal self-determination for marijuana regulation'}

Primary Purpose

Exempt state-legal marijuana activities from the Controlled Substances Act, enable interstate marijuana commerce between legal states, establish FDA regulatory framework for marijuana products, create a federal excise tax, support tribal sovereignty over marijuana regulation, and mandate a traffic safety study.

Policy Domains

{'domain': 'Drug Policy', 'evidence': 'Amends Controlled Substances Act to exempt state-legal marijuana from federal prohibition'} {'domain': 'FDA Regulation', 'evidence': 'Section 7 establishes FDA authority over marijuana products as drugs, food, cosmetics'} {'domain': 'Interstate Commerce', 'evidence': 'Section 4(c) enables interstate marijuana transportation between legal states'} {'domain': 'Tribal Sovereignty', 'evidence': 'Sections 3-4 recognize tribal self-determination for marijuana regulation'}

Legislative Strategy

"Federalism-based approach that defers to states on marijuana legalization while creating a federal regulatory and tax framework, targeting the 75% illicit market"

Legislative Progress

Introduced
Introduced Committee Passed
Apr 17, 2025

Mr. Joyce of Ohio (for himself, Mr. Miller of Ohio, …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Cannabis
7 mentions across 4 clauses
+6 positive -1 negative

Cannabis consumers, Cannabis consumers in legal states, Cannabis product manufacturers

Positive-direction: Cannabis consumers, Cannabis consumers in legal states, Interstate cannabis transport operators, State-legal cannabis businesses, State-legal cannabis industry

Negative-direction: Cannabis product manufacturers

Government
3 mentions across 3 clauses
-3 negative

FDA, Federal drug enforcement, National Highway Traffic Safety Administration

Tribal Nations
2 mentions across 2 clauses
+2 positive

Federally recognized Indian tribes

Criminal Enterprise
1 mention across 1 clause
-1 negative

Illicit marijuana market

Youth Protection
1 mention across 1 clause
+1 positive

Minors (under 18)

Pharmaceuticals
1 mention across 1 clause
-1 negative

Pharmaceutical and tobacco companies

6/10
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Drug Policy Criminal Justice
Actor Mappings
"the_attorney_general"
→ Attorney General
Domains
FDA Regulation Consumer Safety
Actor Mappings
"the_secretary"
→ Secretary of Health and Human Services
"the_commissioner"
→ Commissioner of Food and Drugs

Key Definitions

Terms defined in this bill

2 terms
"Indian Tribe" §4(g)

As defined in section 102 of the Federally Recognized Indian Tribe List Act of 1994

"marijuana product" §7(a)(1)

Any product made or derived from marijuana intended for human or animal consumption, including any component of marijuana

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology